Photo by schluditsch from unsplash
Romosozumab (Evenity) is a new monoclonal antibody therapy for severe osteoporosis in postmenopausal women at high risk of fracture. This article outlines its indications, clinical trial efficacy and side‐effects. Click to show full abstract
Romosozumab (Evenity) is a new monoclonal antibody therapy for severe osteoporosis in postmenopausal women at high risk of fracture. This article outlines its indications, clinical trial efficacy and side‐effects.
Keywords:
romosozumab treatment;
treatment severe;
osteoporosis;
severe osteoporosis
Journal Title: Prescriber
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Prescriber
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!